These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4871401)

  • 61. The immunosuppressive effects of adamantoyl cytarabine. II. Effects on skin allograft rejection by rats and mice.
    Gray GD; Mickelson MM
    Transplantation; 1970 Feb; 9(2):176-8. PubMed ID: 4905927
    [No Abstract]   [Full Text] [Related]  

  • 62. Different role of cyclophosphamide-induced tolerance in heart and skin allograft tolerance.
    Iwai T; Tomita Y; Shimizu I; Zhang Q; Okano S; Minagawa R; Nomoto K; Yasui H
    Transplant Proc; 2001; 33(1-2):173-5. PubMed ID: 11266765
    [No Abstract]   [Full Text] [Related]  

  • 63. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 64. REJECTION OF ALLOGENEIC SKIN GRAFTS AND PRODUCTION OF SPECIFIC HEMAGGLUTININS BY NONIRRADIATED AND IRRADIATED MICE SENSITIZED BY VARIOUS MEANS.
    TYAN ML
    J Immunol; 1965 Jan; 94():22-30. PubMed ID: 14253519
    [No Abstract]   [Full Text] [Related]  

  • 65. Antiserum to lymphocytes and procarbazine compared as immunosuppressants in mice.
    Stewart PB; Cohen V
    Science; 1969 May; 164(3883):1082-3. PubMed ID: 4890177
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The thymus is required for the ability of FTY720 to prolong skin allograft survival across different histocompatibility MHC barriers.
    del Rio ML; Pabst O; Ramirez P; Penuelas-Rivas G; Förster R; Rodriguez-Barbosa JI
    Transpl Int; 2007 Oct; 20(10):895-903. PubMed ID: 17854447
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cyclosporine combined with nonlytic interleukin 2/Fc fusion protein improves immune response to hepatitis B vaccination in a mouse skin transplantation model.
    Li Z; Zhang D; Gao J; Li WX; Zhu JY
    Transplant Proc; 2013; 45(6):2559-64. PubMed ID: 23953581
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dramatic improvement of primary cutaneous amyloidosis with thalidomide.
    An Q; Lin J; Zheng S; Hong Y; Zhang L; Guan X; Xu XG; Chen HD; Gao XH
    Eur J Dermatol; 2011; 21(2):270-1. PubMed ID: 21382777
    [No Abstract]   [Full Text] [Related]  

  • 69. [The effect of a rabbit anti-mouse lymphocyte serum on the survival time of allogenous skin].
    Biege G; von Broen B
    Acta Biol Med Ger; 1969; 22(2):423-6. PubMed ID: 4903489
    [No Abstract]   [Full Text] [Related]  

  • 70. Production of a recombinant form of early pregnancy factor that can prolong allogeneic skin graft survival time in rats.
    Morton H; McKay DA; Murphy RM; Somodevilla-Torres MJ; Swanson CE; Cassady AI; Summers KM; Cavanagh AC
    Immunol Cell Biol; 2000 Dec; 78(6):603-7. PubMed ID: 11114970
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prolongation of skin allograft survival in mice following administration of ALLOTRAP.
    Buelow R; Veyron P; Clayberger C; Pouletty P; Touraine JL
    Transplantation; 1995 Feb; 59(4):455-60. PubMed ID: 7878745
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Successful use of chondroitin-4-sulfate in prolonging survival of skin allografts of adult mice.
    Ashby MW; Nosé Y
    Transplantation; 1971 Jan; 11(1):107-8. PubMed ID: 4927304
    [No Abstract]   [Full Text] [Related]  

  • 73. The influence of histocompatibility and antithymocyte serum on the ability of alloantigenic pretreatment to prolong the survival of mouse skin grafts.
    Cohen N; Latorre JA
    Folia Biol (Praha); 1975; 21(1):33-42. PubMed ID: 1091518
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Thalidomide, an unending story].
    Knabe J
    Pharm Unserer Zeit; 1998 Mar; 27(2):66-7. PubMed ID: 9640056
    [No Abstract]   [Full Text] [Related]  

  • 75. Thalidomide influences the function of macrophages and increases the survival of Plasmodium berghei-infected CBA mice.
    Muniz-Junqueira MI; Silva FO; de Paula-Júnior MR; Tosta CE
    Acta Trop; 2005 May; 94(2):128-38. PubMed ID: 15817259
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of alpha-2 glycoprotein on the immune response.
    Davis WC; Boxer LA
    Transplantation; 1965 Sep; 3(5):673-6. PubMed ID: 5318409
    [No Abstract]   [Full Text] [Related]  

  • 77. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
    Ohzato H; Monaco AP
    Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Survival of first and second-set skin allografts in mice and rats under the influence of cysteine.
    Ryzewski J; Kossakowska M
    Arch Immunol Ther Exp (Warsz); 1974; 22(5):625-8. PubMed ID: 4614758
    [No Abstract]   [Full Text] [Related]  

  • 79. Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation.
    McHugh SM; Rowland TL
    Clin Exp Immunol; 1997 Nov; 110(2):151-4. PubMed ID: 9367395
    [No Abstract]   [Full Text] [Related]  

  • 80. Thalidomide inhibits lipopolysaccharide-induced nitric oxide production and prevents lipopolysaccharide-mediated lethality in mice.
    Noman AS; Koide N; Khuda II; Dagvadorj J; Tumurkhuu G; Naiki Y; Komatsu T; Yoshida T; Yokochi T
    FEMS Immunol Med Microbiol; 2009 Aug; 56(3):204-11. PubMed ID: 19538513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.